跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
GLIMPRO
Approved
STANDARD
GLIMPRO
LifeSquare Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0becdf17d016a099
Company
LifeSquare Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
0becdf17d016a099
Drug Approval Philippines Name
GLIMPRO
Product Name
GLIMPRO
Registration Number
DRP-5170-02
Brand Name
GLIMPRO
Generic Name
GLIMEPIRIDE
Dosage Form
Tablet
Dosage Strength
3mg
Manufacturer
LifeSquare Laboratories, Inc.
Distributor
Bewell Nutraceuticals Corp.
Issuance Date
26 March 2024
Expiry Date
14 February 2029
Pharmacologic Category
BLOOD GLUCOSE LOWERING DRUG (SULFONYLUREAS)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0becdf17d016a099
Type
Standard
Back to Philippines FDA Approvals
GLIMPRO - Philippines FDA Drug Approval Details